Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

31 trials with published results (9%)

Research Maturity

178 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.3%

15 terminated out of 345 trials

Success Rate

92.2%

+5.7% vs benchmark

Late-Stage Pipeline

14%

48 trials in Phase 3/4

Results Transparency

17%

31 of 178 completed with results

Key Signals

31 with results92% success15 terminated

Data Visualizations

Phase Distribution

224Total
Not Applicable (139)
Early P 1 (4)
P 1 (4)
P 2 (29)
P 3 (29)
P 4 (19)

Trial Status

Completed178
Recruiting58
Unknown52
Active Not Recruiting22
Terminated15
Not Yet Recruiting9

Trial Success Rate

92.2%

Benchmark: 86.5%

Based on 178 completed trials

Clinical Trials (345)

Showing 20 of 20 trials
NCT02439775Not ApplicableCompleted

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

NCT04664478Completed

Gene First Approach to Connective Tissue Disease

NCT06615973Recruiting

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

NCT05198674Not ApplicableActive Not Recruiting

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

NCT00009243Recruiting

Natural History of Stroke: Cause and Development

NCT07258290Not ApplicableRecruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

NCT05824923Phase 3Active Not Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

NCT07231757Recruiting

The RADIANCE CED Study

NCT07449325Not ApplicableRecruiting

Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

NCT06976502Enrolling By Invitation

Health eHeart BioBank

NCT06552767Recruiting

Thrombosis and Inflammation in Vessels Initiative (TIVI)

NCT07286578Not ApplicableRecruiting

A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

NCT07214376Not ApplicableRecruiting

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

NCT07115953Not ApplicableRecruiting

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

NCT06907147Not ApplicableRecruiting

SPYRAL GEMINI Pilot Study

NCT07665827Not ApplicableNot Yet Recruiting

Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage

NCT03626688Phase 3Completed

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

NCT05134311Not ApplicableRecruiting

Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies

NCT05655936Not ApplicableActive Not Recruiting

Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial

NCT04040959Phase 2Active Not RecruitingPrimary

Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

Scroll to load more

Research Network

Activity Timeline